Nina Wilson

MathematicsEconomics, Econometrics and FinanceMedicineDecision Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Metformin and physical performance in older people with probable sarcopenia and physical prefrailty or frailty in England (MET-PREVENT): a double-blind, randomised, placebo-controlled trial”.

Metformin and physical performance in older people with probable sarcopenia and physical prefrailty or frailty in England (MET-PREVENT): a double-blind, randomised, placebo-controlled trial

The Lancet Healthy Longevity(2025)10.1016/j.lanhl.2025.100695

N/A

0.553DataRank · unranked

39 citations

Claire McDonald, Nina Wilson, Katherine J Rennie, Michelle Bardgett, Penny Bradley +14 more

Completeness of reporting and risks of overstating impact in cluster randomised trials: a systematic review

The Lancet Global Health(2021)10.1016/s2214-109x(21)00200-x

N/A

0DataRank · unranked

31 citations

Alyssa Platt, John A. Gallis, Kaitlin Tetreault, Christina Easter, Joanne E. McKenzie +80 more